Clinical Trial

Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management

Study acronym: FLARE
Completed
View on ClinicalTrials.gov →
Summary
This is a survey-based study conducted among cardiologists and nephrologists treating people with Atherosclerotic Cardiovascular Disease (ASCVD), Heart Failure (HF) and Chronic Kidney Disease (CKD). Study participants will be recruited to complete self-administered online survey. The purpose of this research is to gather real-world evidence related to attitudes around systemic inflammation and specifically the awareness, perception, drivers and barriers, and use of hsCRP in clinical practice to identify systemic inflammation in people with ASCVD+CKD and HF.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-08-29; most recent amendment 2026-02-09.
Status change: Enrolling by Invitation → Completed 2026-02-09
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-09-23
Trial Details
NCT Number NCT07160829
Lead Sponsor Novo Nordisk A/S
Conditions Atherosclerotic Cardiovascular Disease, Heart Failure, Chronic Kidney Disease
Enrollment 608 participants
Start Date 2025-09-18
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-11